問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberMK-3475-992
NCT Number(ClinicalTrials.gov Identfier)-
Active

2020-03-01 - 2032-06-30

Phase III

Not yet recruiting4

Recruiting3

ICD-10C67.9

Malignant neoplasm of bladder, unspecified

ICD-10Z51.12

Encounter for antineoplastic immunotherapy

ICD-9188.9

Malignant neoplasm of bladder, part unspecified

-

  • Trial Applicant

    Merck Sharp & Dohme (I.A.) LLC

  • Sponsor

    -

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/05/15

Investigators and Locations

Principal Investigator Hsiao-Jen Chung Division of Urology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Wen-Pin Su Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Yu-Li Su Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Po-Jung Su Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator 馮盈勳 Division of Hematology & Oncology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator Jian-Ri Li Division of Urology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Recruiting

Principal Investigator CHUNG-HSIN CHEN

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Study Contacts

- -

Condition/Disease

-

Objectives

-

Test Drug

-

Active Ingredient

-

Dosage Form

-

Dosage

-

Endpoints

-

Inclution Criteria

-

Exclusion Criteria

-

The Estimated Number of Participants

  • Taiwan

    32 participants

  • Global

    520 participants